Downloads

1. March Cytiva Webinar 3/11/2026
2. Engineering Therapeutics With A Structural Approach 12/30/2025

   Faraz A. Choudhury, CEO of Immuto Scientific, discusses target proteins and their adoption of disease-specific conformations that could increase how therapeutics discriminate between diseased and healthy tissues.

3. Room For Improvement: Reformulating Existing Therapeutics 12/30/2025

   We caught up with Jed Litwiniuk, CEO, and Uwe Tigör, CMO, to talk about Auxilius Pharma’s work to improve and reformulate a treatment for chronic stable angina pectoris.

4. Harnessing Mitochondria: A New Frontier In Therapeutic Innovation 12/26/2025

   What if we can replace damaged mitochondria with young and healthy mitochondria? In recent years, a new therapeutic field has evolved: mitochondrial transplantations.

5. Partnering For Progress: Funding The Future Of Rare Disease Research 12/23/2025

   We caught up with Matthew Anderson, MD, Ph.D., to discuss the Oxford-Harrington Rare Disease Centre’s research efforts in drug discovery.

6. In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors 12/23/2025

   By injecting lipid-based nanoparticles encapsulating mRNA and encoding the CAR directly into the bloodstream, developers can effectively reprogram the patient's own immune cells in situ.

7. Small Molecule Enzyme Mimetics In Age-Related Neurodegeneration 12/19/2025

   We caught up with Jack Scannell, CEO of Etheros, to discuss the company’s work to create small molecule enzyme mimetics to tackle age-related neurodegeneration, inflammation, and potentially slow human aging.

8. The Next Frontier In Drug Discovery: Reinventing Old Platforms To Solve New Problems 12/19/2025

   By combining proven technologies with new biological targets, we can create therapies that retain known safety while addressing emerging or previously intractable diseases.

9. An Organ-Chip Platform That Generates Human-Relevant Data At Scale 12/18/2025

   Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.

10. A Revolutionary Consumable Empowering High-Throughput Organ-Chip Studies 12/18/2025

    With 12 independent Emulations in one consumable, Chip-Array optimizes workflows and reduces cell requirements—delivering scalable, physiologically relevant models for advanced research.